Dean Morel
Dean Morel
Send Message
Dean Morel
Stop FollowingDean Morel
ABOUT
Born in New Zealand, living in Australia and having lived for five years in England, Dean Morel is an investing house dad. He nurtures two wonderful kids, two investment portfolios and the best arid garden outside of Arizona.
Before founding FusionInvesting.com (http://www.fusioninvesting.com/), Dean was a business consultant specializing in project and investment management and cost accounting. He helped pioneer the concept of integration management to break down silo mentality on large scale business implementation projects. He consulted to a diverse range of companies from Fortune 500 companies such as Shell and British Airway to start-up technology companies and charitable organisations.
Dean’s ...More focus is on fusing fundamental and technical analysis with lashings of behavioural finance and a sprinkling of options.
Visit Dean's website, FusionInvesting.com (http://www.fusioninvesting.com/)
Before founding FusionInvesting.com (http://www.fusioninvesting.com/), Dean was a business consultant specializing in project and investment management and cost accounting. He helped pioneer the concept of integration management to break down silo mentality on large scale business implementation projects. He consulted to a diverse range of companies from Fortune 500 companies such as Shell and British Airway to start-up technology companies and charitable organisations.
Dean’s ...More focus is on fusing fundamental and technical analysis with lashings of behavioural finance and a sprinkling of options.
Visit Dean's website, FusionInvesting.com (http://www.fusioninvesting.com/)
SNAPSHOT
- Trading frequency: Monthly
- Interests: Dividend stock ideas & income, Forex, Options, Stocks - long, Tech stocks
COMPANY
Currently, there is no company profile for Dean Morel.
Book
Currently, there are no book details for Dean Morel.
LATEST STOCKTALK
more »
Huge day for Biota Feb 5th as GSK report Relenza sales and more importantly should provide guidance on plans to ramp production to 190M+
Feb 3, 2010
Latest Comments
more »
- A few thoughts.If analyst e... on Analysts Estimate Johnson & Johnson Can Outperf...
- Thanks for the great summar... on Some Biotechs May Benefit From Hepatitis C Trea...
- Also, stocks are EXPENSIVE ... on Sell in May and Go Away? Yes.
- Hi OsmanHere is Shiller's d... on Benjamin Graham's Perspective on the Dow Jones
- Thanks for your reply Osman... on Benjamin Graham's Perspective on the Dow Jones
Latest comments on Dean Morel's Articles
LATEST ARTICLES & INSTAPOSTS
more »

